{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:25:59Z","timestamp":1790011559457,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","award":["22-7"],"award-info":[{"award-number":["22-7"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation, often associated with declining health status. It is widely believed that the burden of the disease increases over time, leading to continuous suffering in the patient. Understanding the long-term course of patient-reported outcomes (PROs) and the variability in disease progression is crucial for effective management. The purpose of this research was to investigate the long-term trajectories of health status, respiratory symptoms, and dyspnea in COPD patients over a seven-year period and to identify factors associated with different progression patterns.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methodology<\/jats:title>\n            <jats:p>This longitudinal study followed 70 COPD patients for seven years, with evaluations every six months. Participants underwent pulmonary function tests and completed four PRO measures: St. George\u2019s Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT), Evaluating Respiratory Symptoms in COPD (E-RS), and Dyspnoea-12 (D-12). Annual changes were estimated using linear mixed models and linear regression analysis. The patients were categorized into quartiles based on the rate of decline in forced expiratory volume in one second (FEV<jats:sub>1<\/jats:sub>) and changes in PROs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The group showed a significant deterioration in the FEV<jats:sub>1<\/jats:sub> and PRO measures. FEV<jats:sub>1<\/jats:sub> declined by 25 milliliters annually, while SGRQ Total and CAT scores worsened by 1.4 and 0.6 units per year, respectively. However, substantial variability was observed between individuals. The SGRQ Total score worsened significantly after 1.0 year in the 4th quartile, while the 1st quartile showed improvements at 2.0, 2.5, 3.0, 4.0, 6.0 and 6.5 years. Similarly, while the CAT, E-RS Total and D-12 Total scores deteriorated in the fourth quartile, they remained stable or improved in the first quartile.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The progression of COPD varies widely among individuals. Although some patients experience significant declines, others remain stable or even improve for seven years. These findings challenge the belief that COPD inevitably leads to a constant increase in the burden of disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41687-025-00923-z","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:28:24Z","timestamp":1752226104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Health status, respiratory symptom and dyspnea trajectories in subjects with chronic obstructive pulmonary disease: a seven-year observation in clinical practice"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-7484","authenticated-orcid":false,"given":"Koichi","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kusunose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Nakayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"21","key":"923_CR1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJM198711193172103","volume":"317","author":"B Burrows","year":"1987","unstructured":"Burrows B, Bloom JW, Traver GA, Cline MG (1987) The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 317(21):1309\u20131314. https:\/\/doi.org\/10.1056\/NEJM198711193172103","journal-title":"N Engl J Med"},{"issue":"2","key":"923_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1164\/arrd.1986.134.2.276","volume":"134","author":"DS Postma","year":"1986","unstructured":"Postma DS, de Vries K, Koeter GH, Sluiter HJ (1986) Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis 134(2):276\u2013280. https:\/\/doi.org\/10.1164\/arrd.1986.134.2.276","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"923_CR3","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.21037\/jtd.2019.05.50","volume":"11","author":"M Doneva","year":"2019","unstructured":"Doneva M, Petrova G, Petrova D, Kamusheva M, Petkova V, Tachkov K et al (2019) Chronic obstructive pulmonary disease exacerbations and progression in relation to ambient air pollutants exposure. J Thorac Dis 11(6):2490\u20132497. https:\/\/doi.org\/10.21037\/jtd.2019.05.50","journal-title":"J Thorac Dis"},{"issue":"1","key":"923_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/15412550802587943","volume":"6","author":"PW Jones","year":"2009","unstructured":"Jones PW (2009) Health status and the spiral of decline. COPD 6(1):59\u201363. https:\/\/doi.org\/10.1080\/15412550802587943","journal-title":"COPD"},{"key":"923_CR5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2147\/COPD.S235845","volume":"15","author":"N Afroz","year":"2020","unstructured":"Afroz N, Gutzwiller FS, Mackay AJ, Naujoks C, Patalano F, Kostikas K (2020) Patient-Reported outcomes (PROs) in COPD clinical trials: trends and gaps. Int J Chron Obstruct Pulmon Dis 15:1789\u20131800. https:\/\/doi.org\/10.2147\/COPD.S235845","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"923_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/thx.42.10.773","volume":"42","author":"GH Guyatt","year":"1987","unstructured":"Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW (1987) A measure of quality of life for clinical trials in chronic lung disease. Thorax 42(10):773\u2013778. https:\/\/doi.org\/10.1136\/thx.42.10.773","journal-title":"Thorax"},{"issue":"6","key":"923_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","volume":"145","author":"PW Jones","year":"1992","unstructured":"Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation. The st. George\u2019s respiratory questionnaire. Am Rev Respir Dis 145(6):1321\u20131327. https:\/\/doi.org\/10.1164\/ajrccm\/145.6.1321","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"923_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1586\/17476348.2016.1146595","volume":"10","author":"M Ekstrom","year":"2016","unstructured":"Ekstrom M, Sundh J, Larsson K (2016) Patient reported outcome measures in chronic obstructive pulmonary disease: which to use? Expert Rev Respir Med 10(3):351\u2013362. https:\/\/doi.org\/10.1586\/17476348.2016.1146595","journal-title":"Expert Rev Respir Med"},{"key":"923_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/PROM.S178344","volume":"10","author":"EM Chang","year":"2019","unstructured":"Chang EM, Gillespie EF, Shaverdian N (2019) Truthfulness in patient-reported outcomes: factors affecting patients\u2019 responses and impact on data quality. Patient Relat Outcome Meas 10:171\u2013186. https:\/\/doi.org\/10.2147\/PROM.S178344","journal-title":"Patient Relat Outcome Meas"},{"issue":"10","key":"923_CR10","doi-asserted-by":"publisher","first-page":"e110229","DOI":"10.1371\/journal.pone.0110229","volume":"9","author":"D Kyte","year":"2014","unstructured":"Kyte D, Duffy H, Fletcher B, Gheorghe A, Mercieca-Bebber R, King M et al (2014) Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols. PLoS ONE 9(10):e110229. https:\/\/doi.org\/10.1371\/journal.pone.0110229","journal-title":"PLoS ONE"},{"issue":"1","key":"923_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40271-013-0004-5","volume":"6","author":"D Jahagirdar","year":"2013","unstructured":"Jahagirdar D, Kroll T, Ritchie K, Wyke S (2013) Patient-reported outcome measures for chronic obstructive pulmonary disease: the exclusion of people with low literacy skills and learning disabilities. Patient 6(1):11\u201321. https:\/\/doi.org\/10.1007\/s40271-013-0004-5","journal-title":"Patient"},{"issue":"3 Pt 1","key":"923_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1164\/ajrccm.157.3.9703055","volume":"157","author":"T Hajiro","year":"1998","unstructured":"Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T (1998) Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):785\u2013790. https:\/\/doi.org\/10.1164\/ajrccm.157.3.9703055","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"923_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1378\/chest.110.4.896","volume":"110","author":"M Tsukino","year":"1996","unstructured":"Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T (1996) Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 110(4):896\u2013903. https:\/\/doi.org\/10.1378\/chest.110.4.896","journal-title":"Chest"},{"issue":"1","key":"923_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1164\/ajrccm.163.1.2005009","volume":"163","author":"S Spencer","year":"2001","unstructured":"Spencer S, Calverley PM, Sherwood Burge P, Jones PW (2001) Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163(1):122\u2013128","journal-title":"Am J Respir Crit Care Med"},{"key":"923_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12931-014-0124-z","volume":"15","author":"NK Leidy","year":"2014","unstructured":"Leidy NK, Murray LT, Monz BU, Nelsen L, Goldman M, Jones PW et al (2014) Measuring respiratory symptoms of COPD: performance of the EXACT- respiratory symptoms tool (E-RS) in three clinical trials. Respir Res 15:124. https:\/\/doi.org\/10.1186\/s12931-014-0124-z","journal-title":"Respir Res"},{"issue":"5","key":"923_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/thoraxjnl-2013-204428","volume":"69","author":"NK Leidy","year":"2014","unstructured":"Leidy NK, Sexton CC, Jones PW, Notte SM, Monz BU, Nelsen L et al (2014) Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax 69(5):443\u2013449. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204428","journal-title":"Thorax"},{"issue":"6","key":"923_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/1474515113514891","volume":"13","author":"J Yorke","year":"2014","unstructured":"Yorke J, Armstrong I (2014) The assessment of breathlessness in pulmonary arterial hypertension: reliability and validity of the Dyspnoea-12. Eur J Cardiovasc Nurs 13(6):506\u2013514. https:\/\/doi.org\/10.1177\/1474515113514891","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"1","key":"923_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/thx.2009.118521","volume":"65","author":"J Yorke","year":"2010","unstructured":"Yorke J, Moosavi SH, Shuldham C, Jones PW (2010) Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 65(1):21\u201326. https:\/\/doi.org\/10.1136\/thx.2009.118521","journal-title":"Thorax"},{"issue":"1","key":"923_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1378\/chest.10-0693","volume":"139","author":"J Yorke","year":"2011","unstructured":"Yorke J, Swigris J, Russell AM, Moosavi SH, Ng Man Kwong G, Longshaw M et al (2011) Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 139(1):159\u2013164. https:\/\/doi.org\/10.1378\/chest.10-0693","journal-title":"Chest"},{"issue":"3","key":"923_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4104\/pcrj.2009.00053","volume":"18","author":"P Jones","year":"2009","unstructured":"Jones P, Harding G, Wiklund I, Berry P, Leidy N (2009) Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 18(3):208\u2013215 [pii]. https:\/\/doi.org\/10.4104\/pcrj.2009.00053","journal-title":"Prim Care Respir J"},{"issue":"1","key":"923_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1183\/09031936.00177210","volume":"38","author":"PW Jones","year":"2011","unstructured":"Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML et al (2011) Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 38(1):29\u201335. https:\/\/doi.org\/10.1183\/09031936.00177210","journal-title":"Eur Respir J"},{"issue":"3","key":"923_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N (2009) Development and first validation of the COPD assessment test. Eur Respir J 34(3):648\u2013654. https:\/\/doi.org\/10.1183\/09031936.00102509","journal-title":"Eur Respir J"},{"key":"923_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2466-11-42","volume":"11","author":"PW Jones","year":"2011","unstructured":"Jones PW, Tabberer M, Chen WH (2011) Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT) scores. BMC Pulm Med 11:42. https:\/\/doi.org\/10.1186\/1471-2466-11-42","journal-title":"BMC Pulm Med"},{"issue":"1","key":"923_CR24","doi-asserted-by":"publisher","first-page":"e000196","DOI":"10.1136\/bmjresp-2017-000196","volume":"4","author":"M Kusunose","year":"2017","unstructured":"Kusunose M, Oga T, Nakamura S, Hasegawa Y, Nishimura K (2017) Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities? BMJ Open Respir Res 4(1):e000196. https:\/\/doi.org\/10.1136\/bmjresp-2017-000196","journal-title":"BMJ Open Respir Res"},{"key":"923_CR25","doi-asserted-by":"publisher","unstructured":"Nishimura K, Kusunose M, Sanda R, Mori M, Shibayama A, Nakayasu K (2023) Comparison of predictive properties between tools of patient-reported outcomes: risk prediction for three future events in subjects with COPD. Diagnostics (Basel) 13(13). https:\/\/doi.org\/10.3390\/diagnostics13132269","DOI":"10.3390\/diagnostics13132269"},{"issue":"12","key":"923_CR26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128\u20131138. https:\/\/doi.org\/10.1056\/NEJMoa0909883","journal-title":"N Engl J Med"},{"issue":"5","key":"923_CR27","first-page":"S1","volume":"39","author":"H Sasaki","year":"2001","unstructured":"Sasaki H, Nakamura M, Kida K, Kambe M, Takahashi K, Fujimura M (2001) Reference values for spirogram and blood gas analysis in Japanese adults. J Jpn Respir Soc 39(5):S1\u2013S17","journal-title":"J Jpn Respir Soc"},{"issue":"11","key":"923_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/crj.13427","volume":"15","author":"K Nishimura","year":"2021","unstructured":"Nishimura K, Oga T, Nakayasu K, Taniguchi H, Ogawa T, Watanabe F et al (2021) Comparison between tools for measuring breathlessness: Cross-sectional validation of the Japanese version of the Dyspnoea-12. Clin Respir J 15(11):1201\u20131209. https:\/\/doi.org\/10.1111\/crj.13427","journal-title":"Clin Respir J"},{"issue":"2","key":"923_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.resinv.2012.05.003","volume":"50","author":"T Tsuda","year":"2012","unstructured":"Tsuda T, Suematsu R, Kamohara K, Kurose M, Arakawa I, Tomioka R et al (2012) Development of the Japanese version of the COPD assessment test. Respir Investig 50(2):34\u201339. https:\/\/doi.org\/10.1016\/j.resinv.2012.05.003","journal-title":"Respir Investig"},{"issue":"8","key":"923_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1524-4733.2010.00772.x","volume":"13","author":"NK Leidy","year":"2010","unstructured":"Leidy NK, Wilcox TK, Jones PW, Murray L, Winnette R, Howard K et al (2010) Development of the exacerbations of chronic obstructive pulmonary disease tool (EXACT): a patient-reported outcome (PRO) measure. Value Health 13(8):965\u2013975. https:\/\/doi.org\/10.1111\/j.1524-4733.2010.00772.x","journal-title":"Value Health"},{"issue":"3","key":"923_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1164\/rccm.201005-0762OC","volume":"183","author":"NK Leidy","year":"2011","unstructured":"Leidy NK, Wilcox TK, Jones PW, Roberts L, Powers JH, Sethi S et al (2011) Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med 183(3):323\u2013329. https:\/\/doi.org\/10.1164\/rccm.201005-0762OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"923_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347\u2013365. https:\/\/doi.org\/10.1164\/rccm.201204-0596PP","journal-title":"Am J Respir Crit Care Med"},{"issue":"7245","key":"923_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","volume":"320","author":"PS Burge","year":"2000","unstructured":"Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ (Clinical Res Ed 320(7245):1297\u20131303","journal-title":"BMJ (Clinical Res Ed"},{"issue":"1","key":"923_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.rmed.2006.04.001","volume":"101","author":"T Oga","year":"2007","unstructured":"Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M (2007) Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 101(1):146\u2013153. https:\/\/doi.org\/10.1016\/j.rmed.2006.04.001","journal-title":"Respir Med"},{"issue":"6077","key":"923_CR35","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","volume":"1","author":"C Fletcher","year":"1977","unstructured":"Fletcher C, Peto R (1977) The natural history of chronic airflow obstruction. Br Med J 1(6077):1645\u20131648. https:\/\/doi.org\/10.1136\/bmj.1.6077.1645","journal-title":"Br Med J"},{"issue":"13","key":"923_CR36","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","volume":"365","author":"J Vestbo","year":"2011","unstructured":"Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P et al (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365(13):1184\u20131192. https:\/\/doi.org\/10.1056\/NEJMoa1105482","journal-title":"N Engl J Med"},{"issue":"4","key":"923_CR37","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1378\/chest.124.4.1350","volume":"124","author":"PM Calverley","year":"2003","unstructured":"Calverley PM, Spencer S, Willits L, Burge PS, Jones PW, Group IS (2003) Withdrawal from treatment as an outcome in the ISOLDE study of COPD. Chest 124(4):1350\u20131356. https:\/\/doi.org\/10.1378\/chest.124.4.1350","journal-title":"Chest"},{"issue":"1","key":"923_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1164\/rccm.201106-0992OC","volume":"185","author":"M Nishimura","year":"2012","unstructured":"Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M et al (2012) Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185(1):44\u201352. https:\/\/doi.org\/10.1164\/rccm.201106-0992OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"923_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1183\/09031936.02.00063702","volume":"19","author":"PW Jones","year":"2002","unstructured":"Jones PW (2002) Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 19(3):398\u2013404. https:\/\/doi.org\/10.1183\/09031936.02.00063702","journal-title":"Eur Respir J"},{"key":"923_CR40","doi-asserted-by":"publisher","unstructured":"Alma H, de Jong C, Tsiligianni I, Sanderman R, Kocks J, van der Molen T (2018) Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Respir J 52(3). https:\/\/doi.org\/10.1183\/13993003.00412-2018","DOI":"10.1183\/13993003.00412-2018"},{"key":"923_CR41","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2147\/COPD.S104947","volume":"11","author":"M Morishita-Katsu","year":"2016","unstructured":"Morishita-Katsu M, Nishimura K, Taniguchi H, Kimura T, Kondoh Y, Kataoka K et al (2016) The COPD assessment test and St george\u2019s respiratory questionnaire: are they equivalent in subjects with COPD? Int J Chron Obstruct Pulmon Dis 11:1543\u20131551. https:\/\/doi.org\/10.2147\/COPD.S104947","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"923_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7525-9-112","volume":"9","author":"R Ferrari","year":"2011","unstructured":"Ferrari R, Tanni SE, Caram LM, Naves CR, Godoy I (2011) Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease. Health Qual Life Outcomes 9:112. https:\/\/doi.org\/10.1186\/1477-7525-9-112","journal-title":"Health Qual Life Outcomes"},{"key":"923_CR43","doi-asserted-by":"publisher","DOI":"10.15326\/jcopdf.2023.0415","author":"P Jones","year":"2024","unstructured":"Jones P, Soutome T, Matsuki T, Shinoda M, Hataji O, Miura M et al (2024) Health status progression measured using weekly telemonitoring of COPD assessment test scores over 1 year and its association with COPD exacerbations. Chronic Obstr Pulm Dis. https:\/\/doi.org\/10.15326\/jcopdf.2023.0415","journal-title":"Chronic Obstr Pulm Dis"},{"key":"923_CR44","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.2147\/COPD.S141646","volume":"12","author":"F Rassouli","year":"2017","unstructured":"Rassouli F, Baty F, Stolz D, Albrich WC, Tamm M, Widmer S et al (2017) Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk. Int J Chron Obstruct Pulmon Dis 12:3103\u20133109. https:\/\/doi.org\/10.2147\/COPD.S141646","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"923_CR45","doi-asserted-by":"publisher","unstructured":"Tsai SH, Hung JY, Su PF, Hsu CH, Yu CH, Liao XM et al (2024) Chronic obstructive pulmonary disease trajectory: severe exacerbations and dynamic change in health-related quality of life. BMJ Open Respir Res 11(1). https:\/\/doi.org\/10.1136\/bmjresp-2023-002037","DOI":"10.1136\/bmjresp-2023-002037"},{"key":"923_CR46","doi-asserted-by":"publisher","unstructured":"Calverley PMA, Walker PP (2021) ACO (Asthma-COPD Overlap) is independent from COPD: the case in favour. Diagnostics (Basel) 11(7). https:\/\/doi.org\/10.3390\/diagnostics11071189","DOI":"10.3390\/diagnostics11071189"},{"key":"923_CR47","doi-asserted-by":"publisher","unstructured":"Fujino N, Sugiura H (2021) ACO (Asthma-COPD Overlap) is independent from COPD, a case in favor: A systematic review. Diagnostics (Basel) 11(5). https:\/\/doi.org\/10.3390\/diagnostics11050859","DOI":"10.3390\/diagnostics11050859"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00923-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-025-00923-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00923-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:15:59Z","timestamp":1757222159000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-025-00923-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1186\/s41687-025-00923-z","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Institutional Ethics Committee of the National Center for Geriatrics and Gerontology (No. 1138\u20133) (updated on 12 July 2020). Written informed consent was obtained from all patients before the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}